Neoleukin Therapeutics OverviewNeoleukin Therapeutics Net Income
Profitability analysis for NLTX.
Quarterly Net Income
-$30.93M
↓ 36.59% YoY
As of Mar 2026
Annual Net Income (TTM)
-$98.64M
↑ 10.15% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...